American Association for Cancer Research. Molecular Cancer Therapeutics Minireview Prostaglandin EP receptors: Targets for treatment and prevention of colorectal cancer? Mark A. Hull, Stanley C.W. Ko, and Gillian Hawcroft Molecular Medicine Unit, University of Leeds, St. James’s University Hospital, Leeds, United Kingdom Abstract The importance of the prostaglandin (PG) synthesis pathway, particularly the rate-limiting enzymatic step catalyzed by cyclooxygenase, to colorectal carcinogenesis…
Words 8324 - Pages 34